MindMed
| Company type | Public |
|---|---|
| ISIN | CA60255C8850 |
| Industry | Biotechnology Mental health |
| Founded | May 2019, in Toronto, Canada |
| Founder | Jamon "JR" Rahn Stephen Hurst Scott Freeman Leonard Latchman |
| Headquarters | , U.S. |
Area served | Worldwide |
Key people | |
| Services | |
Number of employees | 57 |
| Subsidiaries | MindMed Discover (Basel, Switzerland) MindMed Pty Ltd. (Perth, Western Australia) |
| Website | mindmed |
Mind Medicine (MindMed) Inc., doing business as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.